Enanta Pharmaceuticals
ENTA
#7363
Rank
โ‚น39.77 B
Marketcap
โ‚น1,378
Share price
5.92%
Change (1 day)
154.70%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -โ‚น6.55 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น65.32 Million. In 2024 the company made an earning of -โ‚น8.69 Billion, an increase over its 2023 earnings that were of -โ‚น11.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น6.55 Billion-24.6%
2024 -โ‚น8.69 Billion-23.87%
2023 -โ‚น11.42 Billion4.39%
2022 -โ‚น10.94 Billion-4.4%
2021 -โ‚น11.44 Billion91.12%
2020 -โ‚น5.99 Billion-407.13%
2019 โ‚น1.94 B-78.63%
2018 โ‚น9.11 B117.97%
2017 โ‚น4.18 B-574.65%
2016 -โ‚น0.89 Billion-110.83%
2015 โ‚น8.13 B-4.5%
2014 โ‚น8.52 B-638.53%
2013 -โ‚น1.59 Billion-137.98%
2012 โ‚น4.16 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
โ‚น148.65 B-2,288.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.901 T-42,800.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น399.53 B-5,980.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.067 T-30,534.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น719.37 B-10,688.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.470 T-21,741.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland